Morgan Stanley analyst Erin Wright maintains Align Tech (NASDAQ:ALGN) with a Overweight and lowers the price target from $438 to $402.
Morgan Stanley Maintains Overweight on Align Tech, Lowers Price Target to $402
Morgan Stanley analyst Erin Wright maintains Align Tech (NASDAQ:ALGN) with a Overweight and lowers the price target from $438 to $402.
Related Posts
uCloudlink Group Reports Partnership With Baiyitong To Launch HyperConn Enabled Devices In China
uCloudlink Group Inc. ("uCloudlink" or the "Company") (NASDAQ:UCL), the world's first and leading mobile data traffic sharing marketplace, has announced new strategic partnership with Baiyitong, a
NLS Pharma Shares Fall After Mazindol ER Interim Data Shows 39% Improvement On Sleepiness Scale
NLS Pharmaceutics Ltd (NASDAQ:NLSP) has announced interim topline data from its Phase 2a trial of its lead product candidate, Quilience (Mazindol…
Morgan Stanley Maintains Underweight on Houlihan Lokey, Raises Price Target to $106
Morgan Stanley analyst Manan Gosalia maintains Houlihan Lokey (NYSE:HLI) with a Underweight and raises the price target from $101 to $106.